Home » UCB Files Flurry of Patent Infringement Suits Over Epilepsy Drug
UCB Files Flurry of Patent Infringement Suits Over Epilepsy Drug
Germany’s UCB filed a whopping 15 patent infringement suits last week in a Delaware court to stave off generic drugmakers Sandoz, Glenmark, Watson and a dozen more from entering the market with copycats of its epilepsy treatment Vimpat, which loses marketing exclusivity in October.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May